Citation Impact
Citing Papers
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
The Oligoadenylate Synthetase Family: An Ancient Protein Family with Multiple Antiviral Activities
2010
Global Genetic Variation at OAS1 Provides Evidence of Archaic Admixture in Melanesian Populations
2012
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
2015
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection
2002
Interferons at age 50: past, current and future impact on biomedicine
2007
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene
2005
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
2013 StandoutNature
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
2007 Standout
T cell exhaustion
2011 Standout
Identifying Host Factors That Regulate Viral Infection
2012
Structure and Mechanism of Receptor Sharing by the IL-10R2 Common Chain
2010
CD8 T cell dysfunction during chronic viral infection
2007
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
T‐cell exhaustion: characteristics, causes and conversion
2010
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection
2004
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
2018 StandoutNobel
Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance
2010
Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus
2008
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Chemokines in the immunopathogenesis of hepatitis C infection #
2008
Pharmacology and therapeutic potential of interferons
2012
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Management of Hepatocellular Carcinoma *
2005 Standout
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
2009
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study
2006
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy
2010
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?
2004
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral Infection
2005
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
IL-10, T cell exhaustion and viral persistence
2007
Synergistic up‐regulation of MCP‐2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti‐tumoral effects
2009
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
Signatures of Archaic Adaptive Introgression in Present-Day Human Populations
2016
Protective and pathogenic functions of macrophage subsets
2011 Standout
Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3
2005 Standout
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
2007
CD4+ T cell responses in hepatitis C virus infection
2007
Chapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
2008
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
2016 StandoutNatureNobel
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Type I Interferon Receptors: Biochemistry and Biological Functions
2007
CCR1 and CCR5 promote hepatic fibrosis in mice
2009
Immunity to hepatitis C virus: stunned but not defeated
2002
Interferon-inducible antiviral effectors
2008 Standout
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†
2004
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
OAS1 Splice Site Polymorphism Controlling Antiviral Enzyme Activity Influences Susceptibility to Type 1 Diabetes
2005
Understanding the T cell immune response in SARS coronavirus infection
2012
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection
2016
Cellular immune responses against hepatitis C virus: the evidence base 2002
2002
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
A fourth Denisovan individual
2017 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
2007
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase
2009
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
2004
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Works of Simon Hellier being referenced
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR
2003
Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
2002
Influence of IL‐10RA and IL‐22 polymorphisms on outcome of hepatitis C virus infection
2007
Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection
2003
Association of Genetic Variants of the Chemokine Receptor Ccr5 and Its Ligands, Rantes and Mcp–2, With Outcome of Hcv Infection
2003
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection
2001
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection
2003
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence
2006